This Solicitation opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

ERYTHROMYCIN TABLETS

Closed

SPE2DP-26-T-4181Federal

Submission Closed07/22/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Dextrose Oral Gel (15g, Package of 3's)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Watermelon-Flavored Oral Rehydration Salts

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE TOPICAL AER

Solicitation # SPE2DP-26-T-4782

This contract is for the procurement of Benzocaine 20 percent oral topical aerosol, provided in 2 fluid ounce containers. The item is regulated by the FDA and is manufactured by Beutlich Pharmaceuticals, LLC. It carries a non-extendable shelf life of 36 months and requires the submission of a Material Safety Data Sheet. Although not officially classified as hazardous, the item must be treated as hazardous material for handling purposes. All shipments must be delivered to the Defense Depot Susquehanna Site East in New Cumberland, Pennsylvania, within 20 days of order. Packaging and marking must strictly adhere to commercial standards and Medical Marking Standard No. 1. The contract specifies a quantity of one unit with a zero percent variance allowed, and inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4781

This contract is for the procurement of Dextrose Oral Gel, specifically 15 gram squeeze tubes with twist-off tips, provided in packages of three. The item is an FDA-regulated drug and must adhere to a non-extendable shelf life of 18 months, with at least 15 months remaining upon delivery to the government. All materials must be marked according to Medical Marking Standard No. 1 and packaged in sealed unit containers and commercial exterior shipping containers to ensure safe delivery. The order consists of one package under NSN 6505014253168, with delivery required within 20 days to the USS Zumwalt DDG 1000. Shipping must be handled via the fastest traceable means, specifically avoiding parcel post. The contract specifies that all packaging and palletization must comply with DLA packaging requirements and the DLA Master List of Technical and Quality Requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Health Sector Supply Chain Fragility and Investment Prioritization Support Services

Solicitation # 77344426S0002

The U.S. International Development Finance Corporation intends to award a one-year sole source purchase order to the API Innovation Center for specialized technical and analytical support. The objective is to identify and assess vulnerabilities within pharmaceutical and health-sector supply chains to uncover investment and resilience opportunities. The selected contractor will be responsible for producing national fragility analyses, integrating complex datasets regarding manufacturing and geopolitics, and preparing 20 to 30 drug-specific supply chain reports focusing on active pharmaceutical ingredients and upstream dependencies. This procurement action is being conducted under the authority of FAR 13.106-1(b). While the government intends to negotiate with a single source, interested vendors may submit responses to the contracting officer by August 31, 2026, at 4:30pm Eastern Time. The government will use these responses to determine whether to proceed with a sole source award or transition to a competitive procurement process.

Office Of Acquisition

POSTED

DEADLINE

6505--Rubidium Rb-82 Generator and Associated Supplies

Solicitation # 36C26127Q0032

The Department of Veterans Affairs, Network Contracting Office 21, intends to award a sole source delivery order to Bracco Diagnostics Inc. for the procurement of Rubidium Rb-82 generators, infusion system leasing, and associated consumables. This acquisition supports Cardiac PET imaging clinical operations at the VA Northern California Health Care System in Mather, California. The requirement is designated as a sole source because the equipment and elution system components are proprietary to Bracco Diagnostics Inc., the original equipment manufacturer. The scope of work includes the delivery of approximately nine generators per year, a 12-month infusion system lease, and various supplies such as accessory packs, waste bottles, elution test vials, and thermal printer paper to ensure compatibility with existing CardioGen 82 systems. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. To be eligible for participation, vendors must be an OEM, authorized dealer, distributor, or reseller and provide documentation proving such authority. Compliance with VAAR 852.212-71 and VAAR 852.212-72 regarding Gray Market and Counterfeit Items is mandatory. Interested parties must submit a capability statement, proposal, or quotation to the contracting officer by September 9, 2026, at 3:00 pm Pacific Standard Time.

261-NETWORK Contract Office 21 (36C261)

POSTED

DEADLINE

Script Center Relocation

Solicitation # PANDHA26P000046644

The Defense Health Agency is soliciting a combined contract under solicitation number PANDHA26P000046644 for the relocation of script center equipment. The project involves moving various assets across multiple military installations, including the relocation of two units within the Cherry Point Exchange in North Carolina, one unit from the Dyess AFB Exchange to the Dyess AFB Clinic in Texas, one unit and lockers from the Ft. Carson Exchange to the Ft. Carson Hospital in Colorado, and one unit and lockers from the Maxwell AFB Exchange in Alabama to the Walter Reed Exchange in Maryland. This opportunity is categorized under NAICS code 325412 and is open to all bidders as there is no set-aside used. The solicitation was posted on August 27, 2026, with a response deadline of September 10, 2026. Primary coordination for this requirement is managed by Sandra Kharan and Saera Khan out of the agency's office in Falls Church, Virginia.

Defense Health Agency

POSTED

DEADLINE

Dapagliflozin Tablets

Solicitation # SPE2D2-26-R-0018

POSTED

DEADLINE

Emergency Supply of Prescription Pharmaceuticals

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThis subcontract for Pharmaceutical Packaging and Labeling Services involves the secondary packaging of finished Naproxen Sodium tablets into 100-count bottles or blister packs. The selected provider must ensure all packaging adheres to specific technical requirements and utilizes DLA-compliant labeling. The contract is issued by the Department of Defense under the Medical Supply Chain Pharm FSA and will be performed at Fort Drum, New York. Interested parties must respond by September 1, 2026, for this requirement categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Contract Manufacturing for Naproxen Sodium TabletsThe Department of Defense, through the Medical Supply Chain Pharm FSA, is seeking a subcontractor for the full-scale manufacturing of Naproxen Sodium 550 mg tablets. The scope of work encompasses the entire production process, including blending, granulation, compression, and coating, with a strict requirement that all in-process quality control measures meet USP standards. This subcontract opportunity is associated with NAICS code 325412 and will be performed at Fort Drum, New York. The solicitation was posted on August 26, 2026, with a response deadline of September 1, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Rehydration Salts for Oral Solution (COTS Pharmaceutical)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days

AI Contract Overview

The contract requires the delivery of 3 bundles (BT) of ERYTHROMYCIN BASE 250 MG TABLETS, with each bundle consisting of 100 tablets, for a total of 300 units, under solicitation SPE2DP-26-T-4181. Delivery must be completed within 20 days to Dyess Air Force Base, Texas, with FOB destination terms placing full transportation responsibility and risk on the contractor. Packaging must comply with commercial standards and adhere strictly to Medical Marking Standard No. 1, which supersedes MIL-STD-129, while preservation and packing must follow MIL-STD-2073-1E, including storage below 86°F. Each unit must be sealed in a protective container, and exterior shipping containers must ensure safe, cost-effective delivery via common carrier. The product has a non-extendable shelf life of 36 months and is identified by NSN 6505-01-075-5095 and NDC 00093-5571-01 for TEVA PHARMACEUTICALS USA, INC. Inspection and acceptance occur at the destination, with all materials required to be marked and documented per DLA’s Medical Marking Standard. Electronic invoicing must be submitted via Wide Area WorkFlow, and the contractor must comply with all applicable DFARS and FAR clauses including safeguarding covered defense information, prohibiting hazardous materials, restricting use of certain telecommunications equipment, and ensuring whistleblower protections. The solicitation mandates submission through DIBBS by July 22, 2026, and includes specific representations regarding entity identification, small business status, and disclosure of covered defense telecommunications equipment. No pricing details are provided in the solicitation, and award criteria or evaluation factors are not explicitly stated, though the procurement falls under simplified acquisition procedures typically leading to a lowest price technically acceptable award.

General Info

TEVA PHARMACEUTICALS to deliver 300 units of ERYTHROMYCIN BASE 250 MG TABLETS to Dyess AFB by July 22, 2026

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

697 LOUISIANA DR BLDG 9201, DYESS AFB, TX, 79607-1367, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4181 Medical Supply Chain Pharma

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJul 16

Solicitation

Response DeadlineJul 22

Deadline has passed

Submission Closed

07/22/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressUSA

Contacts

IMERAH BURNETT

contact@example.gov

+1 (555) 000-0000

Full Description

ERYTHROMYCIN TABLETS
ERYTHROMYCIN BASE 250 MG TABLETS, 100S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
ARBOR NDC 24338-0102-13
FSAB BCHAMBERLIN,,3/13/12
1 BT = 100 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00093-5571-01
SPE2DP-26-T-4181
SECTION B
PR: 7017513315 PRLI: 0001 CONT’D
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017513315 0001 BT 3.000
NSN/MATERIAL:6505010755095
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-075-5095 Quantity: 3 BT Purchase Request: 7017513318QTY: 3 Delivery: 20 days ADO